A small study of symptomatic PAD patients implicated activation of the Notch signaling pathway, a major regulator of vascular smooth muscle cells and macrophages, through the Delta like 4 ligand to the gene expression of »inflamed plaque« leading to unfavorable progression of PAD [82]. Here, DLL4 is linked to peripheral arterial disease.